Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2025-11-04 00:00:00 ET · period of report 2025-10-31 · accession 0001789617-25-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-04 | 2025-10-31 | TVTX | Heerma Peter | Chief COMMERCIAL Off | S - Sale | $35.00 | -5,591 | 119.1K | -4% | -$195.7K | |
| 2025-11-04 | 2025-11-03 | TVTX | Heerma Peter | Chief COMMERCIAL Off | G - Gift | $0.00 | -1,078 | 118.0K | -0.9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-31 | S | D | 5,591 | $35.00 | 119,071 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-03 | G | D | 1,078 | $0.00 | 117,993 | D | — | — |